Pharma Journalist -

Merck, known as MSD outside the U.S. and Canada, has entered into a $700 million funding agreement with Blackstone Life Sciences to support the development of sacituzumab tirumotecan…
Read More...

Avant Technologies Inc., a Nevada-based corporation, and Singapore-based biotechnology firm SGAustria Pte. Ltd. have announced a Joint Venture and License Agreement to pioneer…
Read More...

Cencora, a leading global pharmaceutical solutions company, has announced plans to invest $1 billion through 2030 to strengthen and expand its pharmaceutical distribution network across…
Read More...

Eli Lilly and Company has announced plans to invest $3 billion in a new state-of-the-art manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park.…
Read More...

UCB, a global biopharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for KYGEVVI, a treatment for adults and pediatric patients suffering from…
Read More...

IntoCell Inc., a biotechnology company specializing in next-generation payload and linker technologies for antibody–drug conjugates (ADCs), has entered into a strategic collaboration…
Read More...

Helex, a biotechnology company developing targeted therapies for genetic kidney diseases, has announced the completion of an oversubscribed $3.5 million Seed round led by pi Ventures,…
Read More...

Dewpoint Therapeutics, a biotechnology company pioneering condensate biology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to…
Read More...

Eli Lilly and Company announced plans to invest over $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, strengthening its U.S.…
Read More...

Novo Nordisk has confirmed submitting an unsolicited proposal to acquire U.S.-based Metsera, Inc., a biotechnology company developing early- and mid-stage incretin and non-incretin…
Read More...